Central Line Associated Bloodstream Infection Caused by Kodamaea ohmeri in a Young Child

Authors

Amier Haidar
Farhana Khaja
Brian Simms
Amr Issam Elgehiny
Tracy Omoegbele
Nikita Khetan

Publication Date

12-1-2021

Journal

GERMS - Enabling the Future

Abstract

INTRODUCTION:

CASE REPORT: The patient is a 5-year-old male with a history of short gut syndrome, and total parenteral nutrition (TPN) dependence who presented to the emergency room with a two-day history of productive-cough, rhinorrhea, and fever. Antibiotic therapy was initiated with cefepime and vancomycin for suspected CLABSI. However, within the first twenty-four hours of his admission, his initial blood culture from his central venous catheter became positive for yeast so fluconazole was added due to suspicion of candidemia. During his admission, his initial central line and peripheral blood culture were later speciated as

CONCLUSIONS: This case report further acknowledges that while rare, K. ohmeri is an emerging pathogen that has the potential to be life threatening if not accurately identified and treated with the optimal, empiric antifungal therapy. Due to potentially high mortality and antifungal resistance, this yeast species should be on the differential in patients that present with a central venous catheter and/or other underlying risk factors. Favorable outcomes can be achieved by removing indwelling catheters and administering optimal antifungal therapy.

Keywords

Central line associated bloodstream infection, fungemia, Kodamaea ohmeri, echinocandin

Comments

PMID: 35096680